top of page
Services
About
Publications
CONTACT
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED a randomised trial
The Lancet Diabetes & Endocrinology
S2213-8587(24)00362-0
Next Item
Previous Item
Services
About
Publications
bottom of page